Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: Ophthalmic Epidemiol. 2021 Feb 21;28(6):533–539. doi: 10.1080/09286586.2021.1883675

Table 1.

General characteristics of the study population

Characteristics SD (N=5,015) SHL (N=369,750) AMD (N=97,663)
Age, median (IQR) yrs 41 (23 – 53) 54 (44 – 60) 60 (56 – 62)
Sex, no. (%)
 Male 2,257 (45.00) 196,011 (53.01) 40,186 (41.15)
 Female 2,758 (55.00) 173,739 (46.99) 57,477 (58.85)
Type of benefit plan, no. (%) n= 4,600 n=334,156 n=87,576
PPO 98 (2.13) 8,891 (2.66) 3,574 (4.08)
Comprehensive 157 (3.41) 9,026 (2.70) 2,228 (2.54)
EPO 538 (11.70) 42,979 (12.86) 7,918 (9.04)
HMO 336 (7.30) 25,916 (7.76) 7,211 (8.23)
POS 3,036 (66.00) 215,970 (64.63) 59,372 (67.79)
POS with capitation 28 (0.61) 2,084 (0.62) 605 (0.69)
CDHP 209 (4.54) 16,947 (5.07) 3,965 (4.53)
HDHP 198 (4.30) 12,343 (3.69) 2,703 (3.09)

SD: stargardt disease, SHL: bilateral sensorineural hearing loss, AMD: non-exudative age related macular degeneration, IQR: interquartile range, PPO: preferred provider organization, EPO: exclusive provider organization, HMO: health maintenance organization, POS: point-of-service, CDHP: consumer directed health plan, HDHP: high deductible health plan